DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Siontis KC, Zhang X, Eckard A. et al.
Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States.
Circulation 2018;
138 (15) 1519-1529
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.